Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 23
Filter
Add more filters










Publication year range
1.
J Dent Res ; 89(3): 258-63, 2010 Mar.
Article in English | MEDLINE | ID: mdl-20139342

ABSTRACT

Because the discoordination between swallowing and respiration may cause severe respiratory disorders such as aspiration pneumonia, understanding the neuronal mechanisms underlying such coordination is important. Recently, it was reported that medullary noradrenergic neurons are involved in evoking esophageal-gastric relaxation reflex, leading to a hypothesis that such neurons are also involved in swallowing-respiration coordination. We tested this hypothesis using an in vitro brain-stem preparation obtained from neonatal rats. A temporal inhibition of respiratory rhythm was consistently observed when swallowing activity was induced by electrical stimulations to the supralaryngeal nerve. We found that a broad adrenergic receptor agonist, norepinephrine, markedly blocked the swallowing-induced temporal inhibition of respiration. Further studies revealed that swallowing-induced respiratory inhibition is blocked by an alpha2-adrenergic receptor agonist and enhanced by an alpha2-adrenergic receptor antagonist, indicating an important role of alpha2-adrenergic receptors in regulation of the coordination between swallowing and respiration in vitro.


Subject(s)
Deglutition/physiology , Receptors, Adrenergic, alpha-2/physiology , Respiratory Mechanics/physiology , Adrenergic Agents/pharmacology , Animals , Brain Stem/drug effects , Brain Stem/physiology , Deglutition/drug effects , In Vitro Techniques , Neural Pathways/drug effects , Neurons/physiology , Norepinephrine/physiology , Rats , Rats, Sprague-Dawley , Receptors, Adrenergic, alpha-2/drug effects , Respiratory Mechanics/drug effects , Spinal Cord/drug effects
2.
Oral Microbiol Immunol ; 24(4): 292-8, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19572890

ABSTRACT

INTRODUCTION: The nuclear protein high-mobility group box-1 (HMGB1) acts as a late mediator of inflammation when secreted in the extracellular milieu. In this study, we examined the effect of lipopolysaccharides from periodontal pathogens and apoptotic and necrotic cell death on HMGB1 production in human gingival fibroblasts (HGF). METHODS: HGF from healthy periodontal tissue were cultured and stimulated with lipopolysaccharides (LPS) from Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, and Escherichia coli. We also initiated apoptotic and necrotic cell deaths in HGF. The HMGB1 released in the supernatants from stimulated or dying cells was measured. Immunocytochemical staining against HMGB1 was performed in LPS-stimulated HGF. RESULTS: A significantly higher amount of HMGB1 was detected from necrotic and apoptotic HGF. LPS from A. actinomycetemcomitans, P. gingivalis, and E. coli significantly induced the production of HMGB1 in a time-dependent manner. After 6 h of LPS stimulation, HMGB1 was present in the cytoplasm of cells whereas its location was mainly nuclear after 24 h. CONCLUSIONS: LPS from two major periodontal pathogens, A. actinomycetemcomitans and P. gingivalis, induced HMGB1 secretion from HGF. Apoptotic and necrotic cell deaths resulted in the enhancement of HMGB1. Our results suggest that HGF can be a source of HMGB1 by both active secretion and passive release, and that HMGB1 from HGF may contribute to periodontal tissue destruction.


Subject(s)
Aggregatibacter actinomycetemcomitans/physiology , Cell Death/physiology , Gingiva/metabolism , HMGB1 Protein/biosynthesis , Porphyromonas gingivalis/physiology , Fibroblasts/metabolism , Gingiva/cytology , Humans , Lipopolysaccharides/physiology
3.
J Dent Res ; 87(10): 937-42, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18809747

ABSTRACT

Interleukin (IL)-6 has been considered as an osteolytic factor involved in periodontal disease. However, the function of IL-6 in osteoblastic differentiation of periodontal ligament cells is not clear. We examined the effects of IL-6 and its soluble receptor (sIL-6R) on osteoblastic differentiation of periodontal ligament cells. Osteoblastic differentiation was induced by ascorbic acid. Osteoblast markers, including alkaline phosphatase activity and Runx2 gene expression, were examined. The mechanism of action of IL-6 on osteoblastic differentiation was evaluated by insulin-like growth factor (IGF)-I production and specific inhibitors for the IL-6-signaling molecule. IL-6/sIL-6R enhanced alkaline phosphatase activity and Runx2. Alkaline phosphatase activity was reduced by anti-IGF-I antibody. Mitogen-activated protein kinase and Janus protein tyrosine kinase inhibitors diminished alkaline phosphatase induced by IL-6/sIL-6R. We conclude that IL-6/sIL-6R increases ascorbic-acid-induced alkaline phosphatase activity through IGF-I production, implying that IL-6 acts not only as an osteolytic factor, but also as a mediator of osteoblastic differentiation in periodontal ligament cells.


Subject(s)
Interleukin-6/physiology , Osteoblasts/cytology , Periodontal Ligament/cytology , Adolescent , Adult , Alkaline Phosphatase/biosynthesis , Ascorbic Acid/pharmacology , Cell Differentiation/drug effects , Cell Differentiation/physiology , Core Binding Factor Alpha 1 Subunit/biosynthesis , Humans , Insulin-Like Growth Factor I/biosynthesis , Interleukin-6/pharmacology , MAP Kinase Signaling System , Osteoblasts/metabolism , Periodontal Ligament/drug effects , Receptors, Interleukin-6/physiology , Young Adult
4.
J Periodontal Res ; 42(6): 527-35, 2007 Dec.
Article in English | MEDLINE | ID: mdl-17956465

ABSTRACT

BACKGROUND AND OBJECTIVE: Human periodontal ligament cells are considered to be a key cell type in the regeneration of periodontal tissues because of their unique localization and stem cell-like properties. Interleukin-11 is a multifunctional cytokine known to participate actively in bone metabolism. The purpose of this study was to examine the effect of interleukin-11 on the osteoblastic differentiation of periodontal ligament cells. MATERIAL AND METHODS: Cultured periodontal ligament cells were stimulated with interleukin-11 and/or ascorbic acid, with or without inhibitors for type 1 collagen, janus kinase/signal transducers and activator of transcription, and mitogen-activated protein kinase (MAPK). Osteoblastic differentiation was investigated by examining the alkaline phosphatase activity and gene expression of Runx2, osteocalcin and bone sialoprotein using reverse transcription-polymerase chain reaction. Type 1 collagen and tissue inhibitor of metalloproteinase-1 production were measured using enzyme-linked immunosorbent assays. RESULTS: Interleukin-11 enhanced alkaline phosphatase activity and Runx2, osteocalcin and bone sialoprotein gene expression in the presence of ascorbic acid. Interleukin-11 induced type 1 collagen and tissue inhibitor of metalloproteinase-1 production in periodontal ligament cells. Type 1 collagen inhibitor completely inhibited the alkaline phosphatase activity enhanced by interleukin-11 and ascorbic acid. Furthermore, janus kinase/signal transducers and activator of transcription and MAPK signaling inhibitors reduced interleukin-11/ascorbic acid-induced alkaline phosphatase activity in periodontal ligament cells. CONCLUSION: Interleukin-11/ascorbic acid induced the osteoblastic differentiation of periodontal ligament cells through type 1 collagen production and janus kinase/signal transducers and activator of transcription, and MAPK signaling pathways were involved in this process. These findings suggest that interleukin-11 may function as an osteopromotive cytokine, stimulating the osteoblastic differentiation of periodontal ligament cells mainly through the synthesis of type 1 collagen and possibly by the induction of tissue inhibitor of metalloproteinase-1.


Subject(s)
Interleukin-11/physiology , Osteoblasts/metabolism , Periodontal Ligament/physiology , Alkaline Phosphatase/biosynthesis , Ascorbic Acid/pharmacology , Cell Differentiation , Cells, Cultured , Collagen Type I/biosynthesis , Core Binding Factor Alpha 1 Subunit/biosynthesis , Drug Synergism , Humans , Integrin-Binding Sialoprotein , Interleukin-11/pharmacology , Janus Kinases/physiology , MAP Kinase Signaling System/physiology , Osteocalcin/biosynthesis , Periodontal Ligament/cytology , Periodontal Ligament/drug effects , Reverse Transcriptase Polymerase Chain Reaction , Sialoglycoproteins/biosynthesis , Tissue Inhibitor of Metalloproteinase-1/biosynthesis
5.
J Periodontal Res ; 41(4): 303-10, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16827724

ABSTRACT

BACKGROUND AND OBJECTIVE: Stem cells have been used for regenerative therapies in various fields. The proportion of cells that possess stem cell properties in human periodontal ligament (PDL) cells is not yet well understood. In this study, we quantitatively characterized human PDL cells to clarify their stem cell properties, including self-renewal, multipotency, and stem cell marker expression. MATERIAL AND METHODS: PDL cells were obtained from extracted premolar or wisdom teeth, following which a proliferation assay for self-renewal, a differentiation assay for multipotency, immunostaining for STRO-1, and fluorescence-activated cell sorter (FACS) analysis for stem cell markers (including CD105, CD166, and STRO-1) were performed. RESULTS: Approximately 30% of 400 PDL cells were found to possess replicative potential and formed single-cell colonies, and 30% of these colonies displayed positive staining for STRO-1, 20% differentiated into adipocytes and 30% differentiated into osteoblasts. FACS analysis revealed that PDL cells, including cell populations, expressed the stem cell markers CD105, CD166, and STRO-1. CONCLUSION: The findings of this study indicated that PDL cells possess crucial stem cell properties, such as self-renewal and multipotency, and express the mesenchymal stem cell markers CD105, CD166, and STRO-1 on their cell surface, although there were some variations. Thus, PDL cells can be used for periodontal regenerative procedures.


Subject(s)
Mesenchymal Stem Cells/cytology , Multipotent Stem Cells/cytology , Periodontal Ligament/cytology , Adipogenesis , Adolescent , Adult , Antigens, CD/biosynthesis , Cell Adhesion Molecules, Neuronal/biosynthesis , Cell Proliferation , Cell Separation , Cells, Cultured , Colony-Forming Units Assay , Endoglin , Fetal Proteins/biosynthesis , Humans , Matrix Metalloproteinase 3/biosynthesis , Mesenchymal Stem Cells/metabolism , Multipotent Stem Cells/metabolism , Receptors, Cell Surface/biosynthesis
6.
J Cell Sci ; 117(Pt 8): 1457-68, 2004 Mar 15.
Article in English | MEDLINE | ID: mdl-15020674

ABSTRACT

The muscle-specific, basic helix-loop-helix transcription factor MyoD can induce cells from other mesenchymal lineages to express a skeletal muscle phenotype. Interestingly, MyoD is initially upregulated in myogenic cells incubated with bone morphogenetic proteins (BMPs), a treatment that induces osteogenic differentiation, suggesting that MyoD has a role in BMP-induced osteogenesis of myogenic cells. This possibility is supported by our observations that muscle satellite cells derived from adult MyoD(-/-) mice show severely impaired osteogenic induction by BMP-7 (osteogenic protein 1; OP-1) as indicated by the decreased gene expression of the bone markers alkaline phosphatase, osteocalcin, Runx2/Cbfa1, and Osterix. Ectopic expression of MyoD increased alkaline phosphatase activity and Osterix mRNA expression in response to BMP treatment. Similarly, ectopic expression of MyoD in the pluripotent mesenchymal cell line C3H10T1/2 increased alkaline phosphatase activity induced by BMP-7. Transcription assays showed that transfection with a MyoD-expression vector, but not other myogenic basic helix-loop-helix transcription factors (Myf5, myogenin) increased Runx2/Cbfa1 transactivation of a reporter gene construct containing either six OSE sequences in tandem or a single OSE site. This effect was enhanced by BMP treatment. These studies, therefore, demonstrate that the muscle transcription factor MyoD is required for efficient BMP-induced osteogenesis of myogenic cells and indicate that MyoD might exert its effects through co-operative interactions with Runx2/Cbfa1.


Subject(s)
Cell Differentiation/drug effects , Culture Techniques/methods , MyoD Protein/metabolism , Osteogenesis/drug effects , Proteins/pharmacology , Alkaline Phosphatase/metabolism , Animals , Biomarkers , Cell Line , Core Binding Factor Alpha 1 Subunit , Genes, Reporter , Immunohistochemistry , Mice , Mice, Knockout , Neoplasm Proteins/metabolism , Osteocalcin/metabolism , RNA, Messenger/metabolism , Sp7 Transcription Factor , Transcription Factors/metabolism , Transcriptional Activation
7.
Int J Dent Hyg ; 2(4): 179-84, 2004 Nov.
Article in English | MEDLINE | ID: mdl-16451493

ABSTRACT

The aim of this report is to provide basic information about the historical development, current status and future needs of education and training of dental hygienists in Japan. The first formal training of dental hygienists in Japan started at Tokyo in 1949. Restructure and modification of the dental hygiene education system has been reiterated over the years in order to satisfy the needs of the constantly changing society. Although previously only vocational training was provided for dental hygienists, higher-level education has been conducted. The present legislation of dental hygiene has gone through a complicated process. The student should take the dental hygienist licensing examination which is held once a year by the National Board organized by the Ministry of Health, Labour and Welfare. Currently there are 136 dental hygiene schools and the total enrolment is about 7000. The duration of dental hygiene education course has been prolonged from 2 to 3 years since 2001. In 2004, the 4-year course started. The 2-year dental hygiene education program is expected to be replaced with the 3- and 4-year courses by 2010. The dental hygiene education system in Japan will be improved in many ways as dental hygienists are expected to participate in health promotion and preventive care, and to gain knowledge of the economics and organization of health care in relation to oral hygiene.


Subject(s)
Dental Hygienists/education , Certification/legislation & jurisprudence , Curriculum , Dental Hygienists/legislation & jurisprudence , Dental Hygienists/trends , Forecasting , Health Promotion , Humans , Japan , Licensure/legislation & jurisprudence , Needs Assessment , Preventive Dentistry , Professional Practice/legislation & jurisprudence
8.
Phys Rev Lett ; 88(3): 038301, 2002 Jan 21.
Article in English | MEDLINE | ID: mdl-11801091

ABSTRACT

We have observed interference fringes of electrons in field emission patterns from multiwalled carbon nanotubes at 60 K. The observed fringe pattern is reproduced by calculations based on the formula of Young's interference of two beams. Three-beam interference has also been detected over short time periods. We discuss the reason why Young's interference appears in the electron emission pattern in accelerating fields.

9.
Differentiation ; 68(4-5): 245-53, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11776477

ABSTRACT

Muscle satellite cells are believed to represent a committed stem cell population that is responsible for the postnatal growth and regeneration of skeletal muscle. However, the observation that cultured myoblasts differentiate into osteocytes or adipocytes following treatment with bone morphogenetic proteins (BMPs) or adipogenic inducers, respectively, suggests some degree of plasticity within the mesenchymal lineage. To further investigate this phenomenon, we explore the osteogenic and adipogenic potential of satellite cells isolated from adult mice. Our experiments clearly demonstrate that satellite cell-derived primary myoblasts, expressing myogenic markers such as MyoD, Myf5, Pax7 and desmin, differentiated only into osteocytes or adipocytes following treatment with BMPs or adipogenic inducers, respectively However, satellite cells on isolated muscle fibers cultured in Matrigel readily differentiated into myocytes as well as osteogenic and adipogenic lineages, whereas primary myoblasts did not. Satellite cell-derived primary myoblasts isolated from mice lacking the myogenic transcription factor MyoD (MyoD-/-) differentiate into myocytes poorly in vivo and in vitro (Megeney et al., Genes Dev. 1996; Sabourin et. al, J. Cell Biol., 1999). Therefore, we tested whether MyoD-/- primary myoblasts display increased plasticity relative to wild type cells. Unexpectedly, the osteogenic or adipogenic differentiation potential of MyoD-/- primary myoblasts did not increase compared to wild-type cells. Taken together, these results strongly suggest that muscle satellite cells possess multipotential mesenchymal stem cell activity and are capable of forming osteocytes and adipocytes as well as myocytes.


Subject(s)
Adipocytes/physiology , Cell Differentiation , Muscle, Skeletal/cytology , Osteocytes/physiology , Stem Cells/physiology , Transforming Growth Factor beta , Alkaline Phosphatase/metabolism , Animals , Bone Morphogenetic Protein 7 , Bone Morphogenetic Proteins/pharmacology , Cell Division , Cells, Cultured , Homeodomain Proteins/analysis , Immunohistochemistry , Mice , Mice, Transgenic , MyoD Protein/analysis , PAX7 Transcription Factor
10.
J Dent Res ; 79(10): 1789-93, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11077996

ABSTRACT

Cementum-derived attachment protein (CAP) is a collagenous protein which promotes the attachment and spreading of periodontal cell types. We examined the role of the MEK/MAPK pathway in CAP-mediated fibroblast attachment. Human gingival fibroblasts were labeled with 35S-methionine, and the effect of MAP kinase pathway inhibitor PD98059 on attachment and spreading on CAP-coated dishes was examined. Effect on cell proliferation on CAP-coated plates was determined by [3H]-thymidine uptake. Attachment of human gingival fibroblasts to CAP-containing surfaces activated extracellular-signal-regulated kinases (ERK) ERK-2 and ERK-1. In the absence of serum, the ERKs were activated 15 min after attachment, reaching peak levels after 3 hours, and the activity was sustained for at least 12 hours. The enzyme levels were inhibited in cells treated with PD98059. The PD98059 did not significantly affect the kinetics of fibroblast attachment or the number of cells attaching to CAP-coated plates. However, cell spreading was retarded. DNA synthesis as indicated by [3H]-thymidine uptake was not significantly affected. In contrast to PD98059, attachment, spreading, and [3H]-thymidine uptake were inhibited by the protein tyrosine kinase inhibitor genestein. Our results indicate that the MEK/MAPK pathway participates in CAP-mediated fibroblast spreading, but cell attachment and proliferation do not appear to require ERK-2.


Subject(s)
Cell Adhesion Molecules/metabolism , Cell Adhesion/physiology , Dental Cementum/enzymology , Gingiva/enzymology , Insulin-Like Growth Factor I/metabolism , Mitogen-Activated Protein Kinases/metabolism , Animals , Blotting, Western , Cattle , Cell Division , Cell Movement , Cells, Cultured , DNA/biosynthesis , Enzyme Activation , Enzyme Inhibitors/pharmacology , Fibroblasts/enzymology , Flavonoids/pharmacology , Gingiva/cytology , Humans , Mitogen-Activated Protein Kinase 1/antagonists & inhibitors , Mitogen-Activated Protein Kinase 1/metabolism , Mitogen-Activated Protein Kinase 3 , Mitogen-Activated Protein Kinases/antagonists & inhibitors , Signal Transduction
11.
J Periodontal Res ; 34(3): 154-9, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10384403

ABSTRACT

A specific collagenous cementum attachment protein (CAP) has been identified in human cementum which promotes selective cell migration towards and attachment of various periodontal derived cell populations to root surfaces in vitro. The CAP is known to support attachment of periodontal-derived cell via an RGD motif, which suggests an integrin-mediated mode of attachment. The purpose of the present study was to ascertain which integrin(s) are involved in the attachment of periodontal-derived cells to CAP. The integrins examined comprised subunits of the major receptors for fibronectin (alpha 5) and collagen (alpha 2, alpha 3), as well as the common beta 1 subunit which is present in many extracellular matrix receptors. The wells of 48-well non-tissue culture treated plates were coated with CAP (2 micrograms/ml). For negative and positive controls the wells were coated with bovine serum albumin and fibronectin (5 micrograms/ml), respectively. Human gingival fibroblasts and periodontal ligament fibroblasts were labeled with [3H]-proline, incubated with anti-integrin antibodies and added to the precoated wells. Attachment was assessed after incubating the cells for 1 h at 37 degrees C in the presence of the antibodies. Antibodies to alpha 5 and beta 1 inhibited the attachment of both human gingival fibroblasts and human periodontal ligament fibroblasts to CAP, while anti alpha 2 and alpha 3 antibodies did not affect the attachment. The binding of the fibroblasts to fibronectin was also inhibited by anti-alpha 5 and beta 1 antibodies, both of which are components of the "classical" fibronectin receptor and remained unaffected by the addition of anti-alpha 2 and alpha 3 antibodies. Proteins migrating in SDS-polyacrylamide gels in positions similar to the alpha 5 and beta 1 integrin subunits were present in fractions bound to a column of CAP coupled to Sepharose CL-4B. These results indicate that the attachment to CAP of the periodontal-derived cells, human gingival fibroblasts and human periodontal ligament fibroblasts, is mediated primarily via the integrin alpha 5 beta 1.


Subject(s)
Dental Cementum/metabolism , Fibroblasts/metabolism , Periodontal Ligament/metabolism , Receptors, Fibronectin/metabolism , Animals , Cattle , Cell Adhesion/physiology , Cells, Cultured , Cementogenesis , Dental Cementum/chemistry , Extracellular Matrix Proteins/metabolism , Gingiva/cytology , Humans , Periodontal Ligament/cytology , Protein Binding
12.
Crit Care ; 2(2): 79-80, 1998.
Article in English | MEDLINE | ID: mdl-11056714
13.
Exp Cell Res ; 230(2): 342-51, 1997 Feb 01.
Article in English | MEDLINE | ID: mdl-9024793

ABSTRACT

Bone morphogenetic protein (BMP) is a family of cytokines that induce ectopic bone formation when implanted into muscular tissues. We reported that BMP-2 inhibits the terminal differentiation of C2C12 myoblasts and converts them into osteoblast lineage cells (Katagiri, T., Yamaguchi, A., Komaki, M., Abe, E., Takahashi, N., Ikeda, T., Rosen, V., Wozney, J. M., Fujisawa-Sehara, A., and Suda, T. (1994) J. Cell Biol. 127, 1755-1766). In the present study, we examined the molecular mechanism of the inhibitory effect of BMP-2 on terminal differentiation of myogenic cells. When either MyoD or myogenin cDNA was introduced into C3H10T1/2 (10T1/2) cells with a muscle-specific CAT reporter containing four copies of the right E-box of muscle creatine kinase (MCK) enhancer, the CAT activity was dose-dependently suppressed by BMP-2. Furthermore, BMP-2 inhibited the terminal differentiation of these subclonal 10T1/2 cells that stably expressed MyoD or myogenin into mature myotubes that expressed myosin heavy chain and troponin T. The differentiation of a subclone of the MyoD-transfected NIH3T3 cells into mature muscle cells was also inhibited by BMP-2. BMP-2 induced alkaline phosphatase activity in 10T1/2-derived, but not in NIH3T3-derived MyoD-transfected cells. These cells constitutively expressed exogenous MyoD and myogenin, which were localized exclusively in the nuclei irrespective of the presence and the absence of BMP-2. However, these cells failed to express the mRNAs of endogenous myogenic factors and MCK when cultured with BMP-2. In the electrophoresis mobility shift assay using nuclear extracts of the myogenic cells, MyoD and myogenin bound to the right E-box in the enhancer region of the MCK gene even in the presence of BMP-2. These results suggest that BMP-2 inhibits the terminal differentiation of myogenic cells by suppressing the transcriptional activity of the myogenic factors.


Subject(s)
Bone Morphogenetic Proteins/pharmacology , Cell Differentiation/drug effects , MyoD Protein/genetics , Myogenin/genetics , Transcription, Genetic/drug effects , Transforming Growth Factor beta , 3T3 Cells , Animals , Bone Morphogenetic Protein 2 , CHO Cells , Cell Line , Creatine Kinase/genetics , Cricetinae , Enhancer Elements, Genetic , Humans , Mice , MyoD Protein/metabolism , Myogenin/metabolism , Recombinant Fusion Proteins/pharmacology , Recombinant Proteins
15.
Biochem Biophys Res Commun ; 222(2): 317-22, 1996 May 15.
Article in English | MEDLINE | ID: mdl-8670203

ABSTRACT

Effects of bone morphogenetic protein (BMP)-12 and BMP-13, new members of the BMP family which belong to the transforming growth factor (TGF)-beta superfamily, on terminal differentiation of myoblasts were examined in C2C12 and L-6 myoblasts. When the myoblasts were cultured with BMP-12 or BMP-13, the expression of the myosin heavy chain and the formation of multinucleated myotubes mRNA in L-6 cells. The inhibitory effects of BMP-12 and BMP-13 on myogenic differentiation were similar to the effects of BMP-2, though their potencies were lower than BMP-2. Unlike BMP-2, neither BMP-12 nor BMP-13 induced alkaline phosphatase activity in C2C12 myoblasts. The differences in the biological activities of these new BMPs suggest that the intracellular signalling pathway used by BMP-12 and BMP-13 differs from that of BMP-2.


Subject(s)
Cell Differentiation/drug effects , Muscle, Skeletal/cytology , Osteoblasts/cytology , Proteins/pharmacology , Alkaline Phosphatase/biosynthesis , Animals , Bone Morphogenetic Proteins , Dose-Response Relationship, Drug , Enzyme Induction , Humans , Kinetics , Mice , Muscle, Skeletal/drug effects , Myosin Heavy Chains/biosynthesis , Osteoblasts/drug effects , RNA, Messenger/biosynthesis , Recombinant Proteins/pharmacology , Transforming Growth Factor beta/pharmacology
16.
Cell Tissue Res ; 284(1): 9-17, 1996 Apr.
Article in English | MEDLINE | ID: mdl-8601300

ABSTRACT

Bone morphogenetic proteins (BMPs) induce cartilage and bone formation at both bony and non-bony sites. We examined the possibility whether BMP-2 induces differentiation of osteoblast progenitors into chondroblast lineage cells using organ culture and cell culture prepared from the calvaria of newborn mouse. BMP-2 stimulated alkaline phosphatase activity (a marker of osteoblasts) and induced positive alcian blue staining (a marker of chondroblasts) in a dose- and time-dependent manner in cell cultures isolated from the whole calvaria. BMP-2 also increased the number of round-shaped cells in the cell cultures, which expressed type II collagen. Histologically, the calvaria consisted of not only bone, but also cartilaginous tissues stained with alcian blue, which were located along the endocranial surface of the parietal and occipital bones. When the calvariae were organ-cultured in the presence of BMP-2, the territory of the cartilaginous tissue was markedly increased, and covered most of the occipital bone. A histological examination of the cultured calvariae showed that the bony region of the occipital bone remained unchanged, while the cartilaginous region expanded independent of the bony region. BMP-2 increased the number of proliferating chondroblasts only in the cartilaginous tissue, but never induced new cartilage formation at the bony site. We obtained cells from the anterior portion that contained no cartilage and the posterior portion which contained cartilage, and we subsequently cultured them separately. BMP-2 stimulated ALP activity in all the cultures. However, the treatment with BMP-2 increased the intensity of alcian blue staining only in tissue culture of the posterior portion, but never induced alcian blue staining in tissue culture of the anterior portion. These results indicate that the chondrocytes induced by BMP-2 were derived from the cartilaginous tissue, which had already formed at the surface of the calvarial bone. BMP-2 did not induce differentiation of committed osteoblast progenitors into chondroblast lineage cells.


Subject(s)
Proteins/pharmacology , Alkaline Phosphatase/drug effects , Alkaline Phosphatase/metabolism , Animals , Animals, Newborn , Bone Morphogenetic Proteins , Cartilage, Articular/cytology , Cell Differentiation/drug effects , Humans , Mice , Organ Culture Techniques , Osteoblasts/cytology , Recombinant Proteins/pharmacology , Skull/cytology , Stem Cells/cytology , Stem Cells/drug effects
17.
J Cell Biol ; 127(6 Pt 1): 1755-66, 1994 Dec.
Article in English | MEDLINE | ID: mdl-7798324

ABSTRACT

The implantation of bone morphogenetic protein (BMP) into muscular tissues induces ectopic bone formation at the site of implantation. To investigate the mechanism underlying this process, we examined whether recombinant bone morphogenetic protein-2 (BMP-2) converts the differentiation pathway of the clonal myoblastic cell line, C2C12, into that of osteoblast lineage. Incubating the cells with 300 ng/ml of BMP-2 for 6 d almost completely inhibited the formation of the multinucleated myotubes expressing troponin T and myosin heavy chain, and induced the appearance of numerous alkaline phosphatase (ALP)-positive cells. BMP-2 dose dependently induced ALP activity, parathyroid hormone (PTH)-dependent 3',5'-cAMP production, and osteocalcin production at concentrations above 100 ng/ml. The concentration of BMP-2 required to induce these osteoblastic phenotypes was the same as that required to almost completely inhibit myotube formation. Incubating primary muscle cells with 300 ng/ml of BMP-2 for 6 d also inhibited myotube formation, whereas induced ALP activity and osteocalcin production. Incubation with 300 ng/ml of BMP-2 suppressed the expression of mRNA for muscle creatine kinase within 6 h, whereas it induced mRNA expression for ALP, PTH/PTH-related protein (PTHrP) receptors, and osteocalcin within 24-48 h. BMP-2 completely inhibited the expression of myogenin mRNA by day 3. By day 3, BMP-2 also inhibited the expression of MyoD mRNA, but it was transiently stimulated 12 h after exposure to BMP-2. Expression of Id-1 mRNA was greatly stimulated by BMP-2. When C2C12 cells pretreated with BMP-2 for 6 d were transferred to a colony assay system in the absence of BMP-2, more than 84% of the colonies generated became troponin T-positive and ALP activity disappeared. TGF-beta 1 also inhibited myotube formation in C2C12 cells, and suppressed the expression of myogenin and MyoD mRNAs without inducing that of Id-1 mRNA. However, no osteoblastic phenotype was induced by TGF-beta 1 in C2C12 cells. TGF-beta 1 potentiated the inhibitory effect of BMP-2 on myotube formation, whereas TGF-beta 1 reduced ALP activity and osteocalcin production induced by BMP-2 in C2C12 cells. These results indicate that BMP-2 specifically converts the differentiation pathway of C2C12 myoblasts into that of osteoblast lineage cells, but that the conversion is not heritable.


Subject(s)
Bone Development/physiology , Muscles/drug effects , Osteoblasts/physiology , Proteins/pharmacology , Repressor Proteins , Stem Cells/drug effects , Transcription Factors , Alkaline Phosphatase/biosynthesis , Animals , Bone Morphogenetic Proteins , Cell Differentiation/drug effects , Creatine Kinase/biosynthesis , Cyclic AMP/biosynthesis , DNA-Binding Proteins/biosynthesis , DNA-Binding Proteins/genetics , Dose-Response Relationship, Drug , Helix-Loop-Helix Motifs , Inhibitor of Differentiation Protein 1 , Mice , Muscles/cytology , Muscles/embryology , MyoD Protein/biosynthesis , MyoD Protein/genetics , Myogenin/biosynthesis , Myogenin/genetics , Osteocalcin/biosynthesis , Parathyroid Hormone/biosynthesis , Phenotype , RNA, Messenger/analysis , Time Factors , Transforming Growth Factor beta/pharmacology
18.
Acta Haematol ; 87(4): 202-5, 1992.
Article in English | MEDLINE | ID: mdl-1519436

ABSTRACT

A case of primary adult T-cell lymphoma (ATL) of the breast is described. A 69-year-old woman presented with a painless, rapidly growing lump in her left breast. Staging procedures demonstrated no sign of generalized disease. Following a Patey's mastectomy, 10 courses of adjuvant chemotherapy (CHOP) were successfully administered. The light microscopic, immunohistochemical and molecular genetic analyses of the surgical specimen revealed a primary ATL. Seropositive mothers who breast-feed their children may facilitate the accumulation of T cells carrying HTLV-I in their breasts and thereby increase their risks of developing breast ATL.


Subject(s)
Breast Neoplasms/diagnosis , Lymphoma, T-Cell/diagnosis , Aged , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Blotting, Southern , Breast Neoplasms/therapy , Chemotherapy, Adjuvant , Combined Modality Therapy , DNA, Neoplasm/analysis , Female , HTLV-I Antibodies/blood , Humans , Immunohistochemistry , Lymphoma, T-Cell/therapy , Mammography , Mastectomy, Modified Radical , Ultrasonography, Mammary
19.
Plant Cell ; 3(7): 677-684, 1991 Jul.
Article in English | MEDLINE | ID: mdl-12324609

ABSTRACT

The pin-formed mutant pin 1-1, one of the Arabidopsis flower mutants, has several structural abnormalities in inflorescence axes, flowers, and leaves. In some cases, pin1-1 forms a flower with abnormal structure (wide petals, no stamens, pistil-like structure with no ovules in the ovary) at the top of inflorescence axes. In other cases, no floral buds are formed on the axes. An independently isolated allelic mutant (pin1-2) shows similar phenotypes. These mutant phenotypes are exactly the same in wild-type plants cultured in the presence of chemical compounds known as auxin polar transport inhibitors: 9-hydroxyfluorene-9-carboxylic acid or N-(1-naphthyl)phthalamic acid. We tested the polar transport activity of indole-3-acetic acid and the endogenous amount of free indole-3-acetic acid in the tissue of inflorescence axes of the pin1 mutants and wild type. The polar transport activity in the pin 1-1 mutant and in the pin1-2 mutant was decreased to 14% and 7% of wild type, respectively. These observations strongly suggest that the normal level of polar transport activity in the inflorescence axes is required in early developmental stages of floral bud formation in Arabidopsis and that the primary function of the pin1 gene is auxin polar transport in the inflorescence axis.

20.
Cell Differ Dev ; 28(1): 27-37, 1989 Oct.
Article in English | MEDLINE | ID: mdl-2804733

ABSTRACT

The developmental and morphogenetic process of pistil formation was examined by analysing flowers of wild type and six flower mutants of Arabidopsis thaliana, a small crucifer. The wild type is suggested to originate from two 'pistil-forming units' (carpels) arranged laterally against the axis of the inflorescence at a pistil primordium. Aberrant structures of the pistils of mutants indicate that a set of genes regulate each step of pistil development and morphogenesis, namely arrangement of the units at the pistil primordia, fusion of the units, growth of primordia, formation of the septum in the ovary, and formation of the stigma.


Subject(s)
Brassica/genetics , Genitalia, Male/anatomy & histology , Male , Mutation , Reproduction
SELECTION OF CITATIONS
SEARCH DETAIL
...